Oscar Health Inc (OSCR) stock expected to rise by 15.98%: What’s driving the optimism?

At the time of writing, Oscar Health Inc [OSCR] stock is trading at $16.90, up 6.83%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The OSCR shares have gain 10.17% over the last week, with a monthly amount drifted -4.25%, and not seem to be holding up well over a long-time horizon.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

From an analyst’s perspective:

Oscar Health Inc [NYSE: OSCR] stock has seen the most recent analyst activity on June 26, 2024, when Piper Sandler initiated its Overweight rating and assigned the stock a price target of $25. Previously, Robert W. Baird started tracking the stock with Outperform rating on May 30, 2024, and set its price target to $28. On May 30, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $21 on the stock. Raymond James started tracking the stock assigning a Outperform rating and suggested a price target of $20 on March 22, 2024. BofA Securities upgraded its rating to a Buy and raised its price target to $9 on November 02, 2023. BofA Securities upgraded its rating to Neutral for this stock on June 06, 2023, and upped its price target to $8.75. In a note dated November 16, 2022, Wells Fargo upgraded an Overweight rating on this stock but restated the target price of $4.

For the past year, the stock price of Oscar Health Inc fluctuated between $4.72 and $23.44. Currently, Wall Street analysts expect the stock to reach $19.6 within the next 12 months. Oscar Health Inc [NYSE: OSCR] shares were valued at $16.90 at the most recent close of the market. An investor can expect a potential return of 15.98% based on the average OSCR price forecast.

Analyzing the OSCR fundamentals

According to Oscar Health Inc [NYSE:OSCR], the company’s sales were 6.54B for trailing twelve months, which represents an 45.77% jump. Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -0.0%, Pretax Profit Margin comes in at -0.01%, and Net Profit Margin reading is -0.01%. To continue investigating profitability, this company’s Return on Assets is posted at -0.01, Equity is -0.06 and Total Capital is -0.02. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.29.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 16.15 points at the first support level, and at 15.40 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.50, and for the 2nd resistance point, it is at 18.10.

Ratios To Look Out For

It is important to note that Oscar Health Inc [NYSE:OSCR] has a current ratio of 1.17. Considering the valuation of this stock, the price to sales ratio is 0.61, the price to book ratio is 3.86.

Transactions by insiders

Recent insider trading involved Blackley Richard Scott, Chief Financial Officer, that happened on Jun 06 ’24 when 29978.0 shares were sold. EVP, Chief Insurance Officer, Quane Alessandrea C. completed a deal on Jun 06 ’24 to sell 16793.0 shares. Meanwhile, EVP, Chief Insurance Officer Quane Alessandrea C. sold 668.0 shares on Jun 04 ’24.

Related Posts